Subsidiary19 May 2026, 07:22 pm
Nephrocare to Invest ₹10 Cr in Nepal Subsidiary
AI Summary
Nephrocare Health Services Ltd's board approved audited financial results for FY26 and further investment of up to ₹10 Crore in its Nepalese subsidiary, Nephrocare Health Services Nepal Private Limited. It also granted in-principal approval for providing collateral/security support aggregating up to ₹70 Crore each to its Singapore and Saudi Arabia subsidiaries to enable them to avail credit facilities. M/s. BDO India LLP was re-appointed as Internal Auditor for FY 2026-27.
Key Highlights
- Audited standalone and consolidated financial results for FY26 approved.
- ₹10 Cr investment approved for Nephrocare Health Services Nepal Private Limited.
- ₹70 Cr collateral support approved for Singapore subsidiary.
- ₹70 Cr collateral support approved for Saudi Arabia subsidiary.
- BDO India LLP re-appointed as Internal Auditor for FY 2026-27.